Jeremy Grantham Pacira Bio Sciences, Inc. Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$51.97 - $63.0 $743,171 - $900,900	-14,300 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$30.8 - $52.47 $806,960 - $1.37 Million	-26,200 Reduced 64.69%	14,300 $750,000
Q1 2020 May 14, 2020	BUY	$28.4 - $50.7 $1.15 Million - $2.05 Million	40,500 New	40,500 $1.36 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $946M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.